Glomerulopathy induced by IgG3 anti-trinitrophenyl monoclonal cryoglobulins derived from non-autoimmune mice. We have previously shown that murine IgG3 monoclonal autoantibodies with cryoglobulin activity, derived from lupus-prone mice, are able to induce glomerular lesions resembling the "wire-loop" lesion typically described for human lupus nephritis. In the present study, we have further assessed the nephritogenic potential of four IgG3 anti-hapten, trinitrophenyl (TNP), monoclonal antibodies (mAb) obtained from non-autoimmune mice immunized with TNP-conjugated foreign antigens. Our results showed that two of four IgG3 anti-TNP monoclonal cryoglobulins were capable of inducing glomerular lesions, characterized by voluminous intracapillary thrombi and mesangial deposition of PAS-positive materials, which differed from "wire-loop" lesions generated by IgG3 monoclonal cryoglobulins with autoantibody activities. These anti-TNP monoclonal cryoglobulins, however, failed to induce glomerular lesions when mice were kept at 37°C after the mAb administration. This finding formally proves that the cryoglobulin activity is critically involved in the development of glomerular lesions induced by IgG3 anti-TNP mAb. In addition, we have demonstrated a remarkable difference in the nephritogenic activities of two IgG3 anti-TNP mAb, which exhibit a marked sequence homology in the variable regions of their heavy and light chains (91.5% and 99.1% at the amino acid level, respectively) and an identical isoelectric point. Our results indicate first, that IgG3 monoclonal cryoglobulins are able to generate two different kinds of glomerular lesions, and second, that a subtle difference in variable region sequences may determine not only the nephritogenic activities, but also the type of glomerular lesions mediated by IgG3 cryoglobulins.
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Murine IgG3 have the unique physicochemical property to self-associate via non-immunological Fc-Fc interaction, and a majority of them are able to generate cryoglobulins [1] [2] [3] . In fact, IgG3 are selectively enriched in cryoglobulins isolated from lupus-prone MRL-lpr/lpr mice, from mice injected with bacterial lipopolysaccharides or from mice infected with malaria [21. Recently, we and others have shown that IgG3 monoclonal antibodies (mAb) with anti-IgG2a rheumatoid factor or anti-DNA activity derived from autoimmune MRL-lprllpr and (NZB x NZW)F1 mice are able to induce, in normal mice, severe glomerulonephritis [1, [4] [5] [6] [7] . Light and electron microscopic studies have shown that glomerular lesions induced by these IgG3 monoclonal autoantibodies resemble "wire-loop" lesions, that is, subendothelial accumulation of electron-dense deposits, characteristically described for human lupus nephritis [6, 7] .
There is substantial evidence that the cryoglobulin activity, associated with murine IgG3 heavy chain constant region, appears to play a critical role in the generation of glomerular lesions [4, 5, 8, 9] ; only rheumatoid factor (RF) from MRL-lprI lpr mice that are able to cryoprecipitate-all from the IgG3 subclass-are nephritogenic, and an IgG 1 class switch variant of a nephritogenic IgG3 RF mAb fails to induce glomerular lesions. It is, however, not clear whether any IgG3 monoclonal cryoglobulins (without autoantibody activities) derived from non-autoimmune mice can similarly induce "wire-loop"-like glomerular lesions, and what determines the nephritogenic activity of IgG3 cryoglobulins. Since not all IgG3 cryoglobulins were able to induce glomerular lesions [1, 6, 7] , differences in variable regions of heavy and light chains may influence the potential nephritogenic activity of IgG3 cryoglobulins. To address these questions, we have assessed the nephntogenic potential of IgG3 anti-hapten, trinitrophenyl (TNP), monoclonal cryoglobulins obtained from non-autoimmune mice immunized with TNP-coupled foreign antigens [3] . Analysis of two IgG3 anti-TNP cryogenerating mAb, CB 1 and CB6, was particularly interesting because of a marked sequence homology in the variable regions of their heavy and light chains [10] . Our results indicate that two of four IgG3 anti-TNP monoclonal cryoglobulins were able to induce glomerular lesions, but different from "wire-loop" lesions induced by IgG3 monoclonal cryoglobulins from autoimmune mice. In addition, we found a remarkable difference in the nephritogenic activities of CB 1 and CB6 mAb, despite marked variable region sequence homology. germ-line gene [17] of the VGAM3.8 family. The numbering of amino acid residues and complementarity-determining regions (CDR) are according to Kabat et a! [27] . Identities are indicated by dashes.
established by fusion of spleen cells from C57BL/6 mice immunized with TNP-keyhole limpet hemocyanin, and from l29/Sv mice immunized with DNP-lipopolysaccharide, respectively [3] . A non-cryoprecipitating IgG3 anti-TNP mAb (9A6) was obtained from BALB/c mice immunized with DNP-lipopolysaccharide [3] . mAb were purified from ascites by protein A column chromatography. Isoelectric points (p1) of mAb were determined by analytical isoelectric focusing (IEF) gel electrophoresis as previously described [11] .
cDNA cloning and sequencing Total RNA were prepared from CB 1 and CB6 hybridomas by the LiC1 method [12] . The first strand of cDNA was synthesized with an oligo(dT) primer and 10 g of total RNA [13] . For amplification with Taq DNA polymerase (Cetus Perkin Elmer, Norwalk, Connecticut, USA) [14] , the following primers (5'-3') were used: VHFORCB (AAGTGCCCAAGCACA) and Cy (GGATAGACAGATGG) for the heavy chains, and VkFoRcn (TGTCTGGTGrFGACGGA) and Ck (TGGATGGTGGGAA-GATG) for the light chains. Polymerase chain reaction (PCR) was performed following recommendations of the manufacturer (Cetus Perkin Elmer). The amplified fragments were purified on 2% agarose gel and inserted into pUC18-Sma I vector. The nucleotide sequences corresponding to the variable region of the heavy (VH) and the light (Vk) were determined by the dideoxynucleotide chain termination method using M13 primers [15] , and have been deposited in the EMBL data library (accession number: X70095-X70098). Predicted amino acid sequences were derived from nucleotide consensus sequences of three independent clones for each Vu and Vk.
In vivo treatment
To study the nephritogenicity of IgG3 anti-TNP mAb, (BALB/c X C57BL/6)F1 hybrid (BALB x B6) mice pretreated with pristane were injected intraperitoneally with 1O7 hybridoma cells and sacrificed when moribund (generally 9 to 12 days after the implantation of the hybridomas). In one experiment, IgG3 CB 1 hybridoma cells were similarly injected into BALB X B6 mice, and three animals were sacrificed three, six and nine days after the hybridoma injection. In addition, BALB/c mice were injected intraperitoneally with 15 mg of IgG3 anti-TNP mAb purified from ascites and sacrificed 18 hours later. In some experiments, IgG3 anti-TNP mAb were first kept in a 37°C water bath for one hour to solubilize any cryoprecipitates present in preparations, and then 10 mg of mAb were intravenously injected into BALB/c mice. Then, mice were kept at room temperature or in a warm room at 37°C, and sacrificed three hours later.
Isolation of cryoglobulins
Blood samples collected from the retroorbital plexus were allowed to clot at 37°C for two hours. Aliquots of 100 1 of serum were placed in glass tubes at 4°C for three days. Then, samples were centrifuged at 2,500 rpm for 20 minutes. The precipitates were washed four times with cold PBS (pH 7.3) by centrifugation and finally solubilized in 4 M urea in the same volume as the original sample.
Serological assays
Concentrations of IgG3 in sera and cryoglobulins were determined by IgG3 subclass specific ELISA as described previously [16] . BUN levels were determined by a kinetic method.
Histopathology
Blocks of major organs were obtained at autopsy, and sections were stained with hematoxylin and eosin (HE), periodic acid Schiff (PAS) and phosphotungstic acid reagent. Glomerular lesions were scored on a 0 to 4 scale, in a blinded fashion, based on the intensity and extent of histopathological changes. Kidneys were studied for the deposition of IgG, C3 and fibrinogen by direct staining with fluorescein-isothiocyanate-conjugated rabbit anti-mouse IgG, goat anti-mouse C3 or goat anti-rat fibrinogen (Cappel Laboratories, Cochranville, Pennsylvania, USA). Parts of kidneys were fixed in 2% glutaraldehyde, embedded in Epon and stained with osmium for ultrastructural examination, performed with a Philips EM 400 T electron microscope (Rotterdam, The Netherlands).
Results
Determination of the Vii and Vk nucleotide sequences encoding CBJ and CB6 IgG3 anti-TNP mAb Direct mRNA sequencing of the VH and Vk regions of CB 1 and CB6 IgG3 anti-TNP mAb has previously shown a marked structural homology [10] . However, because of technical difficulties, a number of amino acid residues were not certain or unknown. To determine their complete VH and Vk nucleotide sequences, we performed cDNA cloning by PCR and DNA sequencing of CB 1 and CB6 VH and Vk regions. Comparison of the nucleotide sequence of the VH and Vk regions of CB 1 and CB6 mAb with a data bank indicates that they are encoded by variable-VGAM3 .8, diversity-FL 16.1 (for CB 1 mAb) and FL16.2 (for CB6 mAb), and joining-JH2 genes, and by variableVk19 and joining-Jk2 genes.
Nucleotide and predicted amino acid sequences of CB1 and CB6 VH and Vk regions are presented in Figures 1 and 2 . The When compared with VGAM3.8 germ-line genes, the VH gene encoding CB 1 and CB6 mAb appears to be closely related to the 264 germ-line gene of BALB/c origin [17] . VH CB 1 differs from the 264 germ-line gene by six nucleotide substitutions resulting in five amino acid substitutions, whereas VH CB6 differs from the 264 germ-line gene by one nucleotide substitution only at codon 37, resulting in the amino acid substitution (Met for Va!) (Fig. 1) . This indicates the presence of more somatic mutations in the VH segment of the CB I mAb than that of the CB6 mAb.
Induction of glomerular lesions by CBJ, but not CB6 IgG3 anti-TNP monoclonal cryo globulins
Since both CB 1 and CB6 mAb obtained from C57BL/6 mice immunized with foreign antigens were previously shown to be able to generate cryoglobulins [3] , we have compared their in vivo pathogenic potential in BALB x B6 mice by injecting intraperitoneally hybridoma cells. Serum levels of IgG3 progressively increased from three days after the implantation of hybridoma cells (Table 1) hybridoma-injected mice were comparable to those injected with CB6 hybridoma cells until day 6. At the time of sacrifice (9 days after the hybridoma injection), IgG3 levels were more elevated in mice receiving CB6 hybridoma cells, but similar amounts of cryoglobulins were recoverable from the sera in both groups of mice (Table 1) .
All animals receiving CB 1 hybridoma cells developed diffuse glomerular lesions by day 9. By light microscopy, predominant glomerular changes were characterized by voluminous intracapillary PAS-positive thrombi, almost completely obstructing capillary lumens (Fig. 3A) . Immunofluorescence studies showed markedly positive staining of these glomerular deposits with anti-mouse IgG and anti-mouse C3 antisera (Fig. 4 A, C) .
Mesangial cell proliferation and PMN infiltration were not evident. The phosphotungstic acid and immunofluorescence stainings revealed the presence of substantial amounts of fibrinfibrinogen admixed in the thrombi (Figs. 3B, 4E ). Electron microscopic examination showed a diffuse and massive plugging of glomerular capillaries by amorphous protein deposits, and abundant amounts of electron-dense deposits were occasionally located in the cytoplasm of endothelial cells and in the mesangium (Fig. 5) . Notably, no subendothelial deposits resembling "wire-loop" lesions were observed at any moment after the CB 1 cell injection. In contrast, mice receiving CB6 hybridoma cells developed only minimal changes in glomeruli (Fig. 3 C, D) with little glomerular deposits of IgG, C3 and fibrinogen (Fig. 4 B, D, F) . It should be mentioned that mean values (± 1 SD) of blood BUN concentrations in CB I hybridoma-injected mice at the time of sacrifice were 27.1 4.5 mmollliter, approximately three times higher than those from CB6 hybridoma-injected mice (11.1 0.7 mmollliter; means of pristanetreated control mice were 7.2 0.6 mmol/liter).
To further confirm differences in nephritogenic activities of CB1 and CB6 mAb, 15 mg of each mAb were injected intraperitoneally into BALB/c mice, and the development of glomerular lesions was determined 18 hours later. Light microscopical examination of CB 1 mAb-injected mice showed intracapillary deposits of PAS-and phosphotungstic acid-positive thrombi in the majority of glomeruli, whereas CB6 mAb-injected mice developed deposits only in a limited number of glomeruli (Table  2) . Glomerular lesions observed in CB 1 mAb-infused mice were less severe, but overall glomerular changes were identical to those induced by the injection of hybridoma cells. Notably, no significant PMN infiltration and mesangial cell proliferation were seen. It should be mentioned that essentially identical results were obtained in mice pretreated with pristane prior to intraperitoneal infusion of IgG3 anti-TNP mAb (data not shown). Serum IgG3 levels in CB6 mAb-injected mice were similar or even higher than those of CB 1 mAb-injected mice, although cryoglobulin activities were slightly higher in CB 1 mAb-injected mice (Table 2) . When glomerular lesions were sequentially analyzed from three, six and nine days after the injection of CB 1 hybridoma cells, the progression of the severity of glomerular lesions was observed, but the types of lesions were the same. No significant cellular changes were seen during the observation period, and at day 6 glomerular intracapillary thrombi became detectable in only a fraction of glomeruli, ending up with more diffuse lesions until day 9. It should be mentioned that the glomerular changes induced by the CB 1 mAb are reminiscent of those seen in human cryoglobulin-associated nephropathy. However, several features were lacking: (1) no basement membrane duplication due to mesangial cell interposition was present, and (2) no cylindrical or annular structures were seen within the intracapillary deposits at high power magnification (x 28,000).
Since it has been proposed that the charge characteristics of antibodies may play an important role in the glomerular localization of immune complexes [181, we have determined the p1 of CB 1 and CB6 mAb. In spite of their different nephritogenic activities, both antibodies exhibit an identical p1(8.8), which is expected from the remarkable amino acid sequence homology in the V regions of these two mAb.
Nephritogenic activities of other JgG3 anti-TNP mAb from non-autoimmune mice
Since the CB 1 IgG3 anti-TNP monoclonal cryoglobulin was able to induce glomerular lesions, but of a different type from those induced by IgG3 monoclonal cryoglobulins with autoantibody activities derived from lupus-prone mice [6] , we further studied two other IgG3 anti-TNP monoclonal cryoglobulins % of glomeruli exhibiting cryoglobulin deposits in glomerular capillary lumens (mean of 5 mice 1 SD); 20 glomeruli were examined in each mice; note that histological lesions induced by a single injection of 15 mg CB1 mAb were less severe than those induced by the CB1 hybridoma injection.
(4H 10 and Cl lM) from non-autoimmune mice for potential nephritogenic activities. The implantation of hybridoma cells secreting 4H10 mAb led to the development of glomerular lesions (Table 3) . It should be noted that the type of lesions were identical to those induced by the CB I mAb: voluminous intracapillary and mesangial deposits without significant gbmerular cell proliferation and PMN infiltration. In contrast, no Cl lM hybridoma cells. It should be mentioned that serum levels of IgG3 and cryoglobulins in mice receiving Cl lM hybridoma cells were comparable or even higher than those from mice injected with CB 1 or 4H 10 hybridoma cells at day of sacrifice (Tables 1 and 3 ). Finally, mice receiving hybridoma cells secreting the 9A6 IgG3 anti-TNP mAb lacking cryoglobubin activity generated neither cryoglobulinemia nor glomerular significant glomerular changes occurred in mice injected with lesions. 
Temperature dependency of nephritogenic activities of IgG3
anti-TNP monoc/onal cryoglobulins To study whether the cryoglobulin activity measured in vitro is indeed responsible for the glomerular deposition of the two IgG3 anti-TNP mAb (CB1 and 4HlO), we have analyzed the development of glomerular lesions in mice kept at 37°C. For this purpose, prewarmed IgG3 anti-TNP mAb devoid of cryoglobulins were intravenously injected into BALB/c mice, then mice were kept either at room temperature or in a warm room at 37°C (3 mice in each group). Three hours later animals were sacrificed, and their glomerular lesions were assessed. All CB1 or 4HlO mAb-injected mice kept at room temperature developed typical glomerular lesions described above. The majority of glomeruli showed intracapillary deposits of PAS-and phosphotungstic acid-positive thrombi (Fig. 6) . In contrast, the development of such glomerular lesions were almost completely prevented when mice were kept at 37°C. Notably, serum levels of IgG3 were comparable in both groups of mice (data not shown). Thus, these results indicated that the generation of cryoglobulins in vivo is critical for the development of glomerular lesions induced by CB1 and 4H10 IgG3 anti-TNP mAb.
Discussion
The present study demonstrates that a fraction of IgG3 anti-TNP monoclonal cryoglobulins derived from non-autoimmune mice immunized with TNP-conjugated foreign antigens is able to generate glomerular lesions, but that the type of lesions induced by them markedly differs from those induced by IgG3 monoclonal cryoglobulins with autoantibody activities, established from MRL-lprllpr and (NZB x NZW)F1 mice. The latter cryoglobulins induce "wire-loop" lesions typically described for human lupus nephritis [6, 71 . In addition, we have demonstrated for the first time that murine IgG3 monoclonal cryoglobulins are unable to induce glomerular lesions when mice were kept at 37°C after the mAb administration. This finding formally proves that the cryoglobulin activity is critically involved in the development of glomerular lesions induced by IgG3 anti-TNP mAb. In addition, we have demonstrated a remarkable difference in nephritogenic activities of two IgG3 anti-TNP mAb (CB1 and CB6), which share a marked sequence homology in their VH and Vk regions and an identical isoelectric point.
It is significant that IgG3 monoclonal cryoglobulins without autoantibody activity derived from non-autoimmune mice are IgG3 anti-TNP mAb in BALBIc mice, which were kept either at roon temperature (A) or in a warm room at 37 "C (B). Note the presence of voluminous intracapillary deposits of PAS-positive materials in glomeruli from mice kept at room temperature (A: PAS, x400), which markedly contrasted with the absence of significant glomerular deposits in mice kept at 37°C (B: PAS, x400). able to generate glomerular lesions, but the type of lesions is autoimmune mice [6, 7] . We have recently demonstrated that an different from "wire-loop" lesions induced by IgG3 monoclonal IgG3 monoclonal cryoglobulin with anti-IgG2a rheumatoid faccryoglobulins with RF or anti-DNA activities obtained from tor activity is capable of producing "wire-loop" lesions in mice, Fulpius et a!: Glomerulopathy by JgG3 anti-TNP cryoglobulins independently of the presence of corresponding IgG2a autoantigens [4, 6] , and also in mice depleted of C3 (T. Fulpius et a!, manuscript in preparation). These observations argue against the idea that the development of two different types of glomerular lesions is related to different capacities of IgG3 cryoglobulins to induce immune complex formation and subsequent complement activation. Instead, we favor the idea that the different physicochemical properties of individual cryoglobulins may be responsible for the generation of different glomerular lesions. At present, cellular and molecular mechanisms responsible for the generation of the two different types of glomerular lesions are unknown. However, one of the most significant differences between these two glomerular lesions was the presence or absence of the PMN infiltration. In mice receiving IgG3 RF or anti-DNA cryoglobulins, we observed substantial infiltration of PMN in the early phase of their glomerular lesions [1, [4] [5] [6] , unlike those injected with CB1 hybridoma cells. This raises a possibility that infiltrating PMN may play a significant role in the development of "wire-loop" lesions. If so, one can speculate that the capacity of each IgG3 cryoglobulin to stimulate glomerular cells to produce inflammatory cytokines with chemotactic activities may be a critical factor to determine the type of glomerular lesions generated by IgG3 monoclonal cryoglobulins.
It is striking that CB 1 IgG3 anti-TNP mAb is highly nephritogenic as compared with CB6 IgG3 anti-TNP mAb, despite the fact that their V region sequences are closely related and that their overall charges, as determined by analytical IEF, are identical. The absence of significant changes in charged amino acid residues in their VH and Vk regions further argues against the idea of the focal charge effect to explain the observed differences in nephritogenic activities. However, it should be noted that there exist ten amino acid substitutions in the VH region, particularly in the diversity segment of the CDR3 (4 different amino acids out of 6). Accordingly, one may speculate that the difference in amino acid residues in the V regions could modify physicochemical properties of IgG3 microaggregates, thereby promoting nephritogenic activities of IgG3 cryoglobulins. In this regard, it is worth mentioning that VH segments of CB I mAb are apparently more mutated than those of CB6 mAb, which is consistent with the fact that anti-TNP affinity of the CB 1 mAb is higher than that of the CB6 mAb [3] . This raises an attractive hypothesis that the modification of amino acid residues in the V regions as a result of somatic mutations occurring during the course of immune responses either against self antigens, as is the case of RF and anti-DNA autoantibodies in lupus-prone MRL-Ipr/lpr and (NZB x NZW)F1 mice [19] [20] [21] , or against foreign antigens, may lead to the formation of more pathogenic cryoglobulins. An alternative may be the role of carbohydrate moiety in the nephritogenicity of IgG3 cryoglobulins, since glycosylation appears to contribute to the cryoglobulin activity of certain cryoglobulins [22] . It has been described that a variety of oligosaccharide patterns was obtained from human IgG myeloma proteins [23] , and that the glycosylation pattern of IgG changes during the course of autoimmune rheumatic diseases, most notably in patients with rheumatoid arthritis [24] and in lupus-prone MRL-lpr/lpr mice [25, 26] . Thus, one needs to consider the possibility that a structural difference in oligosaccharide side-chains of IgG3 cryoglobulins may play a role in the expression of their nephritogenic activities.
Our previous and present results further emphasize the importance of physicochemical properties of cryoglobulins in expression of their pathogenic activities; they determine not only the nephritogenic potential, but also the type of glomerular lesions mediated by cryoglobulins. The ability of cryoglobulins to be precipitated in the glomerular capillary lumen and/or to be localized in the subendothelial space is likely to be related to physicochemical properties of each individual cryoglobulin, which may allow interaction with glomerular structures and/or stimulation of glomerular cells to produce inflammatory cytokines. Differences in physicochemical properties of cryoglobulins can be determined by V region amino acid sequences and/or oligosaccharide side-chain sequences. Clearly, the identification of molecular and structural basis responsible for the two different kinds of nephritogenic activities of IgG3 cryoglobulins is of importance for understanding of the pathogenic mechanisms responsible for the development of glomerular lesions associated with cryoglobulins.
